Loading...
Glaukos Corporation
GKOS•NYSE
Healthcare
Medical - Devices
$94.30
$-0.08(-0.08%)
Glaukos Corporation (GKOS) Financial Performance & Income Statement Overview
Review Glaukos Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
21.85%
↑ 21.85%
Operating Income Growth
4.92%
↑ 4.92%
Net Income Growth
-8.70%
↓ 8.70%
Operating Cash Flow Growth
-6.16%
↓ 6.16%
Operating Margin
-25.09%
↓ 25.09%
Gross Margin
75.75%
↑ 75.75%
Net Profit Margin
-30.57%
↓ 30.57%
ROE
-17.27%
↓ 17.27%
ROIC
-11.30%
↓ 11.30%
Glaukos Corporation (GKOS) Income Statement & Financial Overview
Review Glaukos Corporation's (GKOS) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $105.50M | $96.67M | $95.69M | $85.62M |
| Cost of Revenue | $28.64M | $22.58M | $22.55M | $20.26M |
| Gross Profit | $76.86M | $74.09M | $73.14M | $65.36M |
| Gross Profit Ratio | $0.73 | $0.77 | $0.76 | $0.76 |
| R&D Expenses | $36.53M | $34.75M | $34.43M | $30.73M |
| SG&A Expenses | $69.003M | $64.00M | $66.19M | $61.98M |
| Operating Expenses | $105.53M | $98.75M | $100.61M | $92.70M |
| Total Costs & Expenses | $134.16M | $121.33M | $123.16M | $112.96M |
| Interest Income | $2.49M | $2.70M | $2.83M | $3.08M |
| Interest Expense | $1.57M | $1.66M | $3.35M | $3.45M |
| Depreciation & Amortization | $9.82M | $9.00M | $7.93M | $9.98M |
| EBITDA | -$22.30M | -$10.57M | -$29.97M | -$27.03M |
| EBITDA Ratio | -$0.21 | -$0.11 | -$0.31 | -$0.32 |
| Operating Income | -$28.67M | -$24.66M | -$27.47M | -$27.34M |
| Operating Income Ratio | -$0.27 | -$0.26 | -$0.29 | -$0.32 |
| Other Income/Expenses (Net) | -$5.03M | $3.43M | -$20.24M | -$1.40M |
| Income Before Tax | -$33.69M | -$21.23M | -$50.21M | -$40.46M |
| Income Before Tax Ratio | -$0.32 | -$0.22 | -$0.52 | -$0.47 |
| Income Tax Expense | -$114000.00 | $177000.00 | $331000.00 | $377000.00 |
| Net Income | -$33.58M | -$21.41M | -$50.55M | -$40.84M |
| Net Income Ratio | -$0.32 | -$0.22 | -$0.53 | -$0.48 |
| EPS | -$0.60 | -$0.39 | -$1.00 | -$0.82 |
| Diluted EPS | -$0.60 | -$0.39 | -$1.00 | -$0.82 |
| Weighted Avg Shares Outstanding | $55.58M | $55.04M | $50.72M | $49.58M |
| Weighted Avg Shares Outstanding (Diluted) | $55.58M | $55.04M | $50.72M | $49.58M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan